InvestSMART

King River Resources Limited (ASX: KRR) - Announcements

Current share price for KRR : $0.053 0.001 (1.92%)+

ASX company news and announcements for King River Resources Limited (KRR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All King River Resources Limited (KRR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than King River Resources Limited (KRR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for King River Resources Limited (KRR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$79 Update - Notification of buy-back - KRR 3 Apr 2025 9:11AM $0.008 $0.053 risen by 562.50%
$79 Update - Notification of buy-back - KRR 2 Apr 2025 9:01AM $0.008 $0.053 risen by 562.50%
$79 Update - Notification of buy-back - KRR 31 Mar 2025 9:12AM $0.008 $0.053 risen by 562.50%
$79 Update - Notification of buy-back - KRR 28 Mar 2025 8:59AM $0.008 $0.053 risen by 562.50%
$79 Update - Notification of buy-back - KRR 14 Mar 2025 8:22AM $0.009 $0.053 risen by 488.89%
$79 Update - Notification of buy-back - KRR 13 Mar 2025 8:26AM $0.009 $0.053 risen by 523.53%
$79 Update - Notification of buy-back - KRR 12 Mar 2025 8:38AM $0.009 $0.053 risen by 488.89%
$79 Update - Notification of buy-back - KRR 11 Mar 2025 8:23AM $0.008 $0.053 risen by 562.50%
$79 Half Year Accounts 28 Feb 2025 5:35PM $0.009 $0.053 risen by 488.89%
$79 Speewah Final Sale Completion 18 Feb 2025 9:29AM $0.011 $0.053 risen by 381.82%
$79 TVN: TVN completes Speewah contractual arrangements with KRR 18 Feb 2025 9:10AM $0.011 $0.053 risen by 381.82%
$79 2024 Assay Results Completed Tennant Creek 14 Feb 2025 10:51AM $0.011 $0.053 risen by 381.82%
$79 Quarterly Activities/Appendix 5B Cash Flow Report 16 Jan 2025 10:11AM $0.012 $0.053 risen by 341.67%
$79 $2.4million payment received for sale of Speewah Project 2 Dec 2024 12:54PM $0.013 $0.053 risen by 307.69%
$79 Response to ASX Price and Volume Query 28 Nov 2024 4:24PM $0.018 $0.053 risen by 194.44%
$79 Results of Annual General Meeting 15 Nov 2024 12:46PM $0.010 $0.053 risen by 430%
$79 Kurundi High Grade Gold Assay 6 Nov 2024 9:28AM $0.011 $0.053 risen by 381.82%
$79 Trading Halt 4 Nov 2024 10:43AM $0.011 $0.053 risen by 381.82%
$79 Pause in trading 4 Nov 2024 10:20AM $0.011 $0.053 risen by 381.82%
$79 Quarterly Activities/Appendix 5B Cash Flow Report 22 Oct 2024 10:13AM $0.009 $0.053 risen by 488.89%
$79 Notice of Annual General Meeting/Proxy Form 8 Oct 2024 8:43AM $0.009 $0.053 risen by 488.89%
$79 Letter to Shareholders - Annual General Meeting 8 Oct 2024 8:37AM $0.009 $0.053 risen by 488.89%
$79 Appendix 4G and Corporate Governance Statement 20 Sep 2024 6:07PM $0.009 $0.053 risen by 488.89%
$79 Annual Report to shareholders 20 Sep 2024 6:06PM $0.009 $0.053 risen by 488.89%
$79 Tennant Creek Assay Results Langrenus/Providence 13 Sep 2024 9:30AM $0.010 $0.053 risen by 430%

76 - 100 of 356 results

Page 4 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.